MegatrendsMegatrends: not the usual suspects, but who actually profits.View megatrends →

Metrics as of 10/13/2026, 06:33 PM (Berlin time), refresh in progress.

Kneat.com Stock

Kneat.com, Inc.

KSI.TOTSXMarkt
CA$6.50
+0.0% today

Company data

Sector
Healthcare
Industry
Medical - Healthcare Information Services
Country
Ireland
CEO
Edmund Ryan
Employees
343
Market cap
$625 M
IPO
01/03/2017

Kneat.com, Inc. develops and provides specialized software solutions for managing data and documents within highly regulated industries across the United States, Ireland, Canada, and other international markets. Its flagship product, the Kneat Gx platform, is a customizable, ready-to-use application designed to…

Kneat.com stock: price history

12/08/25+13 %12/08/26

1D

+0.0%

1W

+0.2%

1M

+0.6%

6M

+58.5%

YTD

+32.1%

1Y

+13.0%

2Y

+40.1%

5Y

+82.6%

10Y

–

Next earnings date

Next earnings date

11/11/2026 (in 25 days)

Volatility around earnings

~8% stronger price swings than usual

Ask the agents about Kneat.com

Kneat.com stock metrics

P/E

-73.61

P/B

9.87

EV/EBITDA

50.67

RETURN ON EQUITY

-6.3%

NET MARGIN

-21.9%

DEBT/EQUITY

0.42

DIVIDEND YIELD

0.0%

AS OF

31/03/2026

Free float & liquidity

FREE FLOAT

78.0%

FLOAT SHARES

75,008,224

AVG. DAILY VOLUME (30D)

198,989

Dividends & Stock splits

DATERATIO
05/07/20161:3

Comparable stocks

Frequently asked questions about Kneat.com stock

What does Kneat.com do?

Kneat.com, Inc. is a company in the Healthcare sector, Medical - Healthcare Information Services industry, headquartered in Ireland.

The CEO is Edmund Ryan, the company employs around 343 people.

The IPO was on 01/03/2017; the stock trades on TSX under the ticker KSI.TO.

When does Kneat.com report next?

The next earnings date is 11/11/2026.

Around past earnings, price swings were roughly 8% stronger than usual.

Does Kneat.com pay a dividend?

No, Kneat.com currently does not pay a dividend.

Which stocks are comparable to Kneat.com?

Comparable stocks include Hinge Health, HealthEquity, Heartflow, Omada Health, Teladoc Health, SOPHiA GENETICS, Evolent Health and Optima Health.

How can I get Kneat.com stock analyzed?

Clicking "Analyze stock" lets five strategies assess Kneat.com against fixed, published rules and judge it bullish, neutral or bearish. The jury states where it disagrees. A free account starts with 5 credits, a quick check costs 1 credit, a full analysis 2 credits.

Not investment advice. Past performance is not an indicator of future results.